Beckman To Buy Siemens Healthcare Diagnostics' Clinical Microbiology Business

(RTTNews) - Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corp (DHR), Wednesday agreed to purchase the clinical microbiology business of Siemens Healthcare Diagnostics. The financial terms of the deal were not disclosed.

The Siemens clinical microbiology business is an established leader in microbial identification and antibiotic sensitivity testing (ID/AST). The business operates with an installed base of over 6,000 instruments globally. The microbiology product line includes the MicroScan Instruments and MicroScan panels/consumables, along with data management solutions.

Beckman Coulter Diagnostics President Arnd Kaldowski said, "The clinical microbiology business will be an excellent complement to Beckman Coulter's Diagnostics business with a strong reputation and market position."

The transaction is expected to close in Q1 2015.